Last ¥1,287 JPY
Change Today -15.00 / -1.15%
Volume 159.4K
2190 On Other Exchanges
Symbol
Exchange
Hercules
As of 2:10 AM 05/20/13 All times are local (Market data is delayed by at least 15 minutes).

jcl bioassay corp (2190) Snapshot

Open
¥1,259
Previous Close
¥1,302
Day High
¥1,360
Day Low
¥1,250
52 Week High
05/9/13 - ¥1,650
52 Week Low
05/21/12 - ¥285.00
Market Cap
4.3B
Average Volume 10 Days
297.7K
EPS TTM
¥-41.16
Shares Outstanding
3.3M
EX-Date
03/27/14
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for JCL BIOASSAY CORP (2190)

Related News

No related news articles were found.

jcl bioassay corp (2190) Related Businessweek News

No Related Businessweek News Found

jcl bioassay corp (2190) Details

JCL Bioassay Corporation provides contract research services to develop drugs for pharmaceutical companies in Japan. The company offers bio-analysis and testing services in preclinical and clinical drug development processes to measure the drug concentration in biological samples, such as blood or urine taken from animals and humans. It also performs quality and stability testing of pharmaceuticals to ensure that there is no change in quality, formulation, and drug substance at a constant temperature and humidity. In addition, the company provides flow testing to standardize analytical methods for new drugs. JCL Bioassay Corporation was founded in 2005 and is headquartered in Osaka, Japan.

173 Employees
Last Reported Date: 06/29/12
Founded in 2005

jcl bioassay corp (2190) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

jcl bioassay corp (2190) Key Developments

JCL Bioassay Corporation to Report Fiscal Year 2013 Results on May 07, 2013

JCL Bioassay Corporation announced that they will report fiscal year 2013 results on May 07, 2013

JCL Bioassay Corporation, Q2 2013 Earnings Call, Dec 20, 2012

JCL Bioassay Corporation, Q2 2013 Earnings Call, Dec 20, 2012

JCL Bioassay Corporation to Report Q2, 2013 Results on Nov 07, 2012

JCL Bioassay Corporation announced that they will report Q2, 2013 results on Nov 07, 2012

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
2190:JP ¥1,287.00 JPY -15.00

2190 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 2190.
View Industry Companies
 

Industry Analysis

2190

Industry Average

Valuation 2190 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 1.5x
Price/Book 6.2x
Price/Cash Flow NM Not Meaningful
TEV/Sales 0.3x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact JCL BIOASSAY CORP, please visit www.jclbio.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.